MannKind Corp
MNKD
#6414
Rank
NZ$1.31 B
Marketcap
NZ$4.26
Share price
2.53%
Change (1 day)
-52.02%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): NZ$53.95 Million

According to MannKind Corp's latest financial reports the company's current earnings are NZ$0.31 Billion. In 2024 the company made an earning of NZ$53.45 Million, an increase over its 2023 earnings that were of -NZ$18.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$53.95 M0.94%
2024 NZ$53.45 M-394.09%
2023 -NZ$18.18 Million-88.13%
2022 -NZ$0.16 Billion8%
2021 -NZ$0.15 Billion40.84%
2020 -NZ$0.11 Billion10.7%
2019 -NZ$90.91 Million-40.16%
2018 -NZ$0.16 Billion-26.04%
2017 -NZ$0.21 Billion-193.33%
2016 NZ$0.22 B-134.11%
2015 -NZ$0.65 Billion85.72%
2014 -NZ$0.35 Billion3.6%
2013 -NZ$0.34 Billion12.79%
2012 -NZ$0.3 Billion5.58%
2011 -NZ$0.29 Billion-5.72%
2010 -NZ$0.3 Billion-22.51%
2009 -NZ$0.39 Billion-27.37%
2008 -NZ$0.54 Billion3.36%
2007 -NZ$0.52 Billion27.18%
2006 -NZ$0.41 Billion101.63%
2005 -NZ$0.21 Billion50.46%
2004 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.85 B 33,009.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$36.71 B 67,994.73%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$45.06 B 83,488.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.27 B 72,742.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$0.81 B 1,416.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion-605.11%๐Ÿ‡บ๐Ÿ‡ธ USA